Although this could reflect EPCR‐intrinsic effects on cancer cell phenotype, the effect of regionally co‐expressed genes could alternatively explain the EPCR‐high phenotype, and EPCR may represent a clinically useful surrogate marker of chromosome 20q amplification in this setting. The gene discussed is PROCR; the disease is cancer.